Follows women with endometriosis to track pain, cysts and pregnancy
Follows women with endometriosis and healthy women over 24 months, without assigning treatment.
Plain-language title generated from the registry record
Registry title: Guangdong Provincial Endometriosis Clinical Research Cohort
Key facts
- Where
- Guangzhou, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 18 to 45 with endometriosis, and also healthy women of similar age and body mass index as a comparison group.
- Age
- 18 to 45 years
- Sex
- Women only
- Disease stage
- Endometriosis diagnosed from clinical findings, imaging and/or laparoscopy, with complete baseline data including rASRM stage and lesion type.
Main reasons for not taking part
- Endometriosis group: another cancer or severe heart, liver or kidney disease
- Endometriosis group: previous hysterectomy
- Endometriosis group: a mental disorder that prevents follow-up
- Cannot give written informed consent
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
Source: NCT07749053, who can take part
Where in China
- Guangdong Women and Children HospitalGuangzhou, ChinaContact: Li Li, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Li Li
- Trial code
- NCT07749053
- Record updated
- 6 August 2026
- Original description
Endometriosis is a chronic condition that may cause pelvic pain, ovarian cysts, infertility, and recurrent symptoms. This prospective observational cohort study will enroll women aged 18 to 45 years with endometriosis and age- and body mass index-matched healthy women. Participants will receive routine clinical care, and the study will not assign medications or procedures. Baseline clinical information will be collected, and participants will be followed for 24 months, every 3 months during the first year and every 6 months thereafter. The study will assess cyst recurrence, pain recurrence, pregnancy and live birth outcomes, and other long-term clinical outcomes. It will also evaluate associations between disease characteristics, rASRM stage, routine medical treatment, and subsequent clinical and reproductive outcomes, and will support the establishment of an endometriosis clinical research database.Read full original descriptionShow less
Guangdong Provincial Endometriosis Clinical Research Cohort
Endometriosis is a chronic condition that may cause pelvic pain, ovarian cysts, infertility, and recurrent symptoms. This prospective observational cohort study will enroll women aged 18 to 45 years with endometriosis and age- and body mass index-matched healthy women. Participants will receive routine clinical care, and the study will not assign medications or procedures. Baseline clinical information will be collected, and participants will be followed for 24 months, every 3 months during the first year and every 6 months thereafter. The study will assess cyst recurrence, pain recurrence, pregnancy and live birth outcomes, and other long-term clinical outcomes. It will also evaluate associations between disease characteristics, rASRM stage, routine medical treatment, and subsequent clinical and reproductive outcomes, and will support the establishment of an endometriosis clinical research database.
Inclusion: Inclusion Criteria:; Female participants aged 18 to 45 years. Able and willing to provide written informed consent. For the endometriosis cohort: diagnosis of endometriosis based on clinical findings, imaging, and/or laparoscopy; For the endometriosis cohort: availability of complete baseline clinical data, including revised American Society for Reproductive Medicine stage and lesion type; For the healthy control cohort: healthy women matched by age and body mass index to participants in the endometriosis cohort; For the healthy control cohort: regular menstrual cycles of 28 to 30 days.
Exclusion: For the endometriosis cohort: concurrent malignant tumor or severe cardiac, hepatic, or renal disease; For the endometriosis cohort: previous hysterectomy. For the endometriosis cohort: a mental disorder that prevents adherence to study follow-up; -.